Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Maxel Pharma Oy
OY
Active
Y-tunnus 2276780-0
Eerikinkartanontie 286, 02880
Veikkola
Business and other management consultancy activities
·
NACE 7020
Est. 2009 · 16 years old
— employees
Share
Finland
/
Companies
/
Business and other management consultancy activities
/
Maxel Pharma Oy
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (3)
MK
Max Kristian Nummila
Deputy Member
Deputy Member
2024
NM
Nina Margareta Nummila
Chief Executive Officer
Chief Executive Officer
2015
KK
Kim Kristian Nummila
Deputy Chief Executive Officer
Deputy Chief Executive Officer
2015
Former (3)
HT
Harri Tapio Rekilä
Audit
Audit
2017 – 2020
VO
Virve Orvokki Hiljanen
Audit
Audit
2020 – 2023
TT
Ture Theodor Grönberg
Deputy Member
Deputy Member
2015 – 2024
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Maxel Pharma Oy
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
